Cellular DNA, Ras p21 and p53 expression in the carcinogenesis of adenomatous colorectal polyps

Citation
Xh. Zhang et al., Cellular DNA, Ras p21 and p53 expression in the carcinogenesis of adenomatous colorectal polyps, ANAL QUAN C, 21(5), 1999, pp. 449-453
Citations number
12
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
ISSN journal
08846812 → ACNP
Volume
21
Issue
5
Year of publication
1999
Pages
449 - 453
Database
ISI
SICI code
0884-6812(199910)21:5<449:CDRPAP>2.0.ZU;2-K
Abstract
OBJECTIVE: To explore the possible roles of cellular DNA, oncogene ras and tumor suppressor gene p53 in the carcinogenesis of colorectal adenomatous p olyps (CAP). STUDY DESIGN: Cellular DNA content, oncogene ras and tumor suppressor gene p53 expression at the protein level were quantitatively studied with flow c ytometry (FCM) in 16 cases of CAP with mild epithelial dysplasia (CAP-MD), 16 cases of CAP with moderate/severe epithelial dysplasia (CAP-M/SD) and 11 cases of cancer in adenomatous polyps (CIAP). RESULTS: Nuclear DNA contents of CAP-M/SD (DNA [DI] = 1.11 +/- 0.06) and CI AP (DI = 1.29 +/- 0.03) Tr,ere significantly higher than those of CAP-MD (D I = 1.06 +/- 0.06) and normal controls (DI = 1.00, P <.005) and were in the FCM DNA aneuploidy range. The rates and amount las determined by the fluor esence index) of mutant p53 protein expression in CAP-M/SD and CIAP were si gnificantly higher than those in the control and CAP-MD groups. Positive ra tes of ras p21 expression were all high in CAP-MD, CAP-M/SD and CIAP (80%, 75% and 100%, respectively), yet the in-tensity of expression in the last w as significantly stronger than those in the former two groups. DNA aneuploi d, ras p21 and p53 coexpression were found in 10 of II cases of CIAP. CONCLUSION: The results suggest that cellular DNA, ras p21 and p53 are al i nvolved in the carcinogenesis of CAP. Clinically, the appearance of DNA ane uploidy, ras p21 or p53 overexpression should be considered markers of mali gnant conversion in CAP.